U.S. Eligibility and Preventable Cardiovascular, Diabetes, and Kidney Outcomes From Semaglutide in the SELECT Trial.
作者信息
Yan Hongmei, Karthikeyan Hridhay, Fan Wenjun, Yang Qin, Wong Nathan D
机构信息
Mary and Steve Wen Cardiovascular Division, Department of Medicine, University of California, Irvine, California, USA; Division of Endocrinology, Department of Medicine, University of California, Irvine, California, USA; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
Mary and Steve Wen Cardiovascular Division, Department of Medicine, University of California, Irvine, California, USA.
出版信息
JACC Adv. 2025 Jun;4(6 Pt 2):101773. doi: 10.1016/j.jacadv.2025.101773. Epub 2025 May 21.
Abstract
摘要
Zotero 插件